Fingerprint
Dive into the research topics of 'Randomized phase III trial comparing weekly docetaxel plus cisplatin versus docetaxel monotherapy every 3 weeks in elderly patients with advanced non-small-cell lung cancer: The intergroup trial JCOG0803/WJOG4307L'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically